-
- MATSUMOTO Akira
- Department of Hematology, Gunma University Graduate School of Medicine
-
- OGAWA Yoshiyuki
- Department of Hematology, Gunma University Graduate School of Medicine
-
- KAJITA Mikiya
- Department of Hematology, Gunma University Graduate School of Medicine
-
- KOBAYASHI Nobuhiko
- Department of Hematology, Gunma University Graduate School of Medicine
-
- MIYAZAWA Yuri
- Department of Hematology, Gunma University Graduate School of Medicine
-
- YANAGISAWA Kunio
- Infection Control and Prevention Center, Gunma University Hospital
-
- ISHIZAKI Takuma
- Department of Hematology, Gunma University Graduate School of Medicine
-
- TAZAWA Masayuki
- Department of Rehabilitation, Gunma University Graduate School of Medicine
-
- WADA Naoki
- Department of Rehabilitation, Gunma University Graduate School of Medicine
-
- SOURI Masayoshi
- Department of Public Health and Hygiene, Yamagata University Faculty of Medicine
-
- ICHINOSE Akitada
- Faculty of Medicine, Yamagata University
-
- HANDA Hiroshi
- Department of Hematology, Gunma University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 当院における後天性血友病A患者のリハビリテーションと転帰に関する臨床的検討
Description
<p>The main goals of acquired hemophilia A (AHA) therapy are to arrest bleeding using bypass agents and eradicate FVIII inhibitors using immunosuppressive therapy (IST). We treated a total of 25 patients with AHA in the past 10 years at Gunma University Hospital. Fifteen patients (60%) underwent rehabilitation during hospitalization. The median time from admission to the start of rehabilitation was 31 days (7-142 days). Median FVIII activity at the start of rehabilitation was 11.3% (2.9-79.8%), and median FVIII inhibitor was 2.1 BU/ml (<5.0-46.8 BU/ml). Only one patient (6.7%) had a bleeding event triggered by rehabilitation.</p>
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 65 (10), 1270-1275, 2024
The Japanese Society of Hematology
